InCarda Therapeutics
Newark, CA
InCarda Therapeutics, Inc. operates as a biotechnology company. The Company develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. InCarda Therapeutics focuses on the development and commercialization of therapies for acute cardiovascular conditions.
incardatherapeutics.comCompany Details
Founded
- 2009
Employees
- Between 10 - 100 employees
Raised
- $86,376,976
Headquarters Location
- Newark, CA
Public
- No
Acquired
- No
CEO
- N/A
Founders
- Carlos SchulerJohn S. PattonGregory M. MarcusAdam FreundNarsi Rangachari
Company Collections
These are collections InCarda Therapeutics is a part of. Click on the collection name to view similar companies.